Liposarcoma Dedifferentiated

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-06-13
Clinical Trial Update: Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas [Phase 2]
Open-label Phase 2 study of SPH4336, a CDK4/6 inhibitor, in locally advanced or metastatic liposarcoma has been terminated with results post…